中国健康受试者口服GW117胶囊的随机、双盲、安慰剂对照、剂量递增的I期临床试验
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial of oral administration of GW117 capsules in healthy Chinese subjects
研究健康受试者单次口服不同剂量GW117胶囊的耐受性及药代动力学,研究健康受试者多次口服不同剂量GW117胶囊的耐受性及药代动力学,研究饮食对健康受试者口服GW117胶囊药代动力学的影响,为后期临床试验提供依据。
[Translation] To study the tolerance and pharmacokinetics of a single oral administration of different doses of GW117 capsules in healthy subjects, to study the tolerance and pharmacokinetics of multiple oral administration of different doses of GW117 capsules in healthy subjects, and to study the effect of diet on the pharmacokinetics of oral GW117 capsules in healthy subjects, so as to provide a basis for later clinical trials.
100 Clinical Results associated with Nanjing Guangwei Medical Technology Co., Ltd.
0 Patents (Medical) associated with Nanjing Guangwei Medical Technology Co., Ltd.
100 Deals associated with Nanjing Guangwei Medical Technology Co., Ltd.
100 Translational Medicine associated with Nanjing Guangwei Medical Technology Co., Ltd.